AZENTA INC (AZTA) Stock Price, Forecast & Analysis

NASDAQ:AZTA • US1143401024

29.83 USD
+1.19 (+4.16%)
At close: Feb 18, 2026
29.83 USD
0 (0%)
After Hours: 2/18/2026, 4:02:01 PM

AZTA Key Statistics, Chart & Performance

Key Statistics
Market Cap1.37B
Revenue(TTM)594.95M
Net Income(TTM)-57.85M
Shares46.06M
Float45.60M
52 Week High47.55
52 Week Low23.91
Yearly Dividend0
Dividend Yield0%
EPS(TTM)0.54
PE55.24
Fwd PE28.87
Earnings (Next)05-05
IPO1995-02-02
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
AZTA short term performance overview.The bars show the price performance of AZTA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15 -20 -25

AZTA long term performance overview.The bars show the price performance of AZTA in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40 -50

The current stock price of AZTA is 29.83 USD. In the past month the price decreased by -28.4%. In the past year, price decreased by -36%.

AZENTA INC / AZTA Daily stock chart

AZTA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
AZTA Full Technical Analysis Report

AZTA Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to AZTA. While AZTA has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
AZTA Full Fundamental Analysis Report

AZTA Financial Highlights

Over the last trailing twelve months AZTA reported a non-GAAP Earnings per Share(EPS) of 0.54. The EPS increased by 14.89% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -2.79%
ROE -3.37%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%12.5%
Sales Q2Q%0.77%
EPS 1Y (TTM)14.89%
Revenue 1Y (TTM)-8.4%
AZTA financials

AZTA Forecast & Estimates

14 analysts have analysed AZTA and the average price target is 40.22 USD. This implies a price increase of 34.82% is expected in the next year compared to the current price of 29.83.

For the next year, analysts expect an EPS growth of 51.12% and a revenue growth 4.59% for AZTA


Analysts
Analysts75.71
Price Target40.22 (34.83%)
EPS Next Y51.12%
Revenue Next Year4.59%
AZTA Analyst EstimatesAZTA Analyst Ratings

AZTA Ownership

Ownership
Inst Owners111.91%
Ins Owners0.63%
Short Float %9.18%
Short Ratio5.33
AZTA Ownership

AZTA Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
TMO THERMO FISHER SCIENTIFIC INC20.69188.452B
DHR DANAHER CORP24.56145.876B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28140.2445.865B
A AGILENT TECHNOLOGIES INC20.9735.035B
IQV IQVIA HOLDINGS INC13.0727.889B
MTD METTLER-TOLEDO INTERNATIONAL29.7527.511B
WAT WATERS CORP22.6419.135B
ILMN ILLUMINA INC23.217.803B
WST WEST PHARMACEUTICAL SERVICES31.6317.495B
MEDP MEDPACE HOLDINGS INC26.5412.062B

About AZTA

Company Profile

AZTA logo image Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company is headquartered in Burlington, Massachusetts and currently employs 3,000 full-time employees. The firm provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The firm's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The firm's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The firm's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.

Company Info

AZENTA INC

200 Summit Drive, 6Th Floor

Burlington MASSACHUSETTS US

Employees: 3000

AZTA Company Website

AZTA Investor Relations

Phone: 19782622400

AZENTA INC / AZTA FAQ

Can you describe the business of AZENTA INC?

Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company is headquartered in Burlington, Massachusetts and currently employs 3,000 full-time employees. The firm provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The firm's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The firm's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The firm's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.


What is the stock price of AZENTA INC today?

The current stock price of AZTA is 29.83 USD. The price increased by 4.16% in the last trading session.


Does AZENTA INC pay dividends?

AZTA does not pay a dividend.


How is the ChartMill rating for AZENTA INC?

AZTA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Where is AZENTA INC (AZTA) stock traded?

AZTA stock is listed on the Nasdaq exchange.


What is the Price/Earnings (PE) ratio of AZENTA INC (AZTA)?

The PE ratio for AZENTA INC (AZTA) is 55.24. This is based on the reported non-GAAP earnings per share of 0.54 and the current share price of 29.83 USD.


What is the employee count for AZTA stock?

AZENTA INC (AZTA) currently has 3000 employees.